Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Mar 04, 2025
Episode
265
Soundcloud
Share
Join us in a live discussion with Drs. Jared Weiss and Jessica Lin talk about the pros and cons of targeted therapy in early-stage NSCLC, from their anecdotes about the debate to future studies in this setting.
Guest
Jessica J. Lin
MD
Associate Professor of Medicine
Harvard Medical School
Attending Physician, Massachusetts General Hospital
Jared Weiss
MD
Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology
University of North Carolina
